A systematic literature review of evidence-based clinical practice for rare diseases: What are the perceived and real barriers for improving the evidence and how can they be overcome?

Ana Rath, Valérie Salamon, Sandra Peixoto, Virginie Hivert, Martine Laville, Berenice Segrestin, Edmund A.M. Neugebauer, Michaela Eikermann, Vittorio Bertele, Silvio Garattini, Jørn Wetterslev, Rita Banzi, Janus C. Jakobsen, Snezana Djurisic, Christine Kubiak, Jacques Demotes-Mainard, Christian Gluud

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Background: Evidence-based clinical practice is challenging in all fields, but poses special barriers in the field of rare diseases. The present paper summarises the main barriers faced by clinical research in rare diseases, and highlights opportunities for improvement. Methods: Systematic literature searches without meta-analyses and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. Results: Barriers specific to rare diseases comprise the difficulty to recruit participants because of rarity, scattering of patients, limited knowledge on natural history of diseases, difficulties to achieve accurate diagnosis and identify patients in health information systems, and difficulties choosing clinically relevant outcomes. Conclusions: Evidence-based clinical practice for rare diseases should start by collecting clinical data in databases and registries; defining measurable patient-centred outcomes; and selecting appropriate study designs adapted to small study populations. Rare diseases constitute one of the most paradigmatic fields in which multi-stakeholder engagement, especially from patients, is needed for success. Clinical research infrastructures and expertise networks offer opportunities for establishing evidence-based clinical practice within rare diseases.

Original languageEnglish
Article number556
JournalTrials
Volume18
Issue number1
DOIs
Publication statusPublished - Nov 22 2017

Fingerprint

Evidence-Based Practice
Rare Diseases
Research
Health Information Systems
Patient Participation
Telephone
Registries
Meta-Analysis
Communication
Databases
Population

Keywords

  • Assessment
  • ECRIN
  • European Clinical Infrastructure Networks
  • Evidence-based clinical practice
  • Evidence-based medicine
  • Randomised clinical trials
  • Rare diseases
  • Specific barriers

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Cite this

A systematic literature review of evidence-based clinical practice for rare diseases : What are the perceived and real barriers for improving the evidence and how can they be overcome? / Rath, Ana; Salamon, Valérie; Peixoto, Sandra; Hivert, Virginie; Laville, Martine; Segrestin, Berenice; Neugebauer, Edmund A.M.; Eikermann, Michaela; Bertele, Vittorio; Garattini, Silvio; Wetterslev, Jørn; Banzi, Rita; Jakobsen, Janus C.; Djurisic, Snezana; Kubiak, Christine; Demotes-Mainard, Jacques; Gluud, Christian.

In: Trials, Vol. 18, No. 1, 556, 22.11.2017.

Research output: Contribution to journalReview article

Rath, A, Salamon, V, Peixoto, S, Hivert, V, Laville, M, Segrestin, B, Neugebauer, EAM, Eikermann, M, Bertele, V, Garattini, S, Wetterslev, J, Banzi, R, Jakobsen, JC, Djurisic, S, Kubiak, C, Demotes-Mainard, J & Gluud, C 2017, 'A systematic literature review of evidence-based clinical practice for rare diseases: What are the perceived and real barriers for improving the evidence and how can they be overcome?', Trials, vol. 18, no. 1, 556. https://doi.org/10.1186/s13063-017-2287-7
Rath, Ana ; Salamon, Valérie ; Peixoto, Sandra ; Hivert, Virginie ; Laville, Martine ; Segrestin, Berenice ; Neugebauer, Edmund A.M. ; Eikermann, Michaela ; Bertele, Vittorio ; Garattini, Silvio ; Wetterslev, Jørn ; Banzi, Rita ; Jakobsen, Janus C. ; Djurisic, Snezana ; Kubiak, Christine ; Demotes-Mainard, Jacques ; Gluud, Christian. / A systematic literature review of evidence-based clinical practice for rare diseases : What are the perceived and real barriers for improving the evidence and how can they be overcome?. In: Trials. 2017 ; Vol. 18, No. 1.
@article{6e8b770271754dbf852875ceead777ce,
title = "A systematic literature review of evidence-based clinical practice for rare diseases: What are the perceived and real barriers for improving the evidence and how can they be overcome?",
abstract = "Background: Evidence-based clinical practice is challenging in all fields, but poses special barriers in the field of rare diseases. The present paper summarises the main barriers faced by clinical research in rare diseases, and highlights opportunities for improvement. Methods: Systematic literature searches without meta-analyses and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. Results: Barriers specific to rare diseases comprise the difficulty to recruit participants because of rarity, scattering of patients, limited knowledge on natural history of diseases, difficulties to achieve accurate diagnosis and identify patients in health information systems, and difficulties choosing clinically relevant outcomes. Conclusions: Evidence-based clinical practice for rare diseases should start by collecting clinical data in databases and registries; defining measurable patient-centred outcomes; and selecting appropriate study designs adapted to small study populations. Rare diseases constitute one of the most paradigmatic fields in which multi-stakeholder engagement, especially from patients, is needed for success. Clinical research infrastructures and expertise networks offer opportunities for establishing evidence-based clinical practice within rare diseases.",
keywords = "Assessment, ECRIN, European Clinical Infrastructure Networks, Evidence-based clinical practice, Evidence-based medicine, Randomised clinical trials, Rare diseases, Specific barriers",
author = "Ana Rath and Val{\'e}rie Salamon and Sandra Peixoto and Virginie Hivert and Martine Laville and Berenice Segrestin and Neugebauer, {Edmund A.M.} and Michaela Eikermann and Vittorio Bertele and Silvio Garattini and J{\o}rn Wetterslev and Rita Banzi and Jakobsen, {Janus C.} and Snezana Djurisic and Christine Kubiak and Jacques Demotes-Mainard and Christian Gluud",
year = "2017",
month = "11",
day = "22",
doi = "10.1186/s13063-017-2287-7",
language = "English",
volume = "18",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A systematic literature review of evidence-based clinical practice for rare diseases

T2 - What are the perceived and real barriers for improving the evidence and how can they be overcome?

AU - Rath, Ana

AU - Salamon, Valérie

AU - Peixoto, Sandra

AU - Hivert, Virginie

AU - Laville, Martine

AU - Segrestin, Berenice

AU - Neugebauer, Edmund A.M.

AU - Eikermann, Michaela

AU - Bertele, Vittorio

AU - Garattini, Silvio

AU - Wetterslev, Jørn

AU - Banzi, Rita

AU - Jakobsen, Janus C.

AU - Djurisic, Snezana

AU - Kubiak, Christine

AU - Demotes-Mainard, Jacques

AU - Gluud, Christian

PY - 2017/11/22

Y1 - 2017/11/22

N2 - Background: Evidence-based clinical practice is challenging in all fields, but poses special barriers in the field of rare diseases. The present paper summarises the main barriers faced by clinical research in rare diseases, and highlights opportunities for improvement. Methods: Systematic literature searches without meta-analyses and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. Results: Barriers specific to rare diseases comprise the difficulty to recruit participants because of rarity, scattering of patients, limited knowledge on natural history of diseases, difficulties to achieve accurate diagnosis and identify patients in health information systems, and difficulties choosing clinically relevant outcomes. Conclusions: Evidence-based clinical practice for rare diseases should start by collecting clinical data in databases and registries; defining measurable patient-centred outcomes; and selecting appropriate study designs adapted to small study populations. Rare diseases constitute one of the most paradigmatic fields in which multi-stakeholder engagement, especially from patients, is needed for success. Clinical research infrastructures and expertise networks offer opportunities for establishing evidence-based clinical practice within rare diseases.

AB - Background: Evidence-based clinical practice is challenging in all fields, but poses special barriers in the field of rare diseases. The present paper summarises the main barriers faced by clinical research in rare diseases, and highlights opportunities for improvement. Methods: Systematic literature searches without meta-analyses and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. Results: Barriers specific to rare diseases comprise the difficulty to recruit participants because of rarity, scattering of patients, limited knowledge on natural history of diseases, difficulties to achieve accurate diagnosis and identify patients in health information systems, and difficulties choosing clinically relevant outcomes. Conclusions: Evidence-based clinical practice for rare diseases should start by collecting clinical data in databases and registries; defining measurable patient-centred outcomes; and selecting appropriate study designs adapted to small study populations. Rare diseases constitute one of the most paradigmatic fields in which multi-stakeholder engagement, especially from patients, is needed for success. Clinical research infrastructures and expertise networks offer opportunities for establishing evidence-based clinical practice within rare diseases.

KW - Assessment

KW - ECRIN

KW - European Clinical Infrastructure Networks

KW - Evidence-based clinical practice

KW - Evidence-based medicine

KW - Randomised clinical trials

KW - Rare diseases

KW - Specific barriers

UR - http://www.scopus.com/inward/record.url?scp=85029449182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029449182&partnerID=8YFLogxK

U2 - 10.1186/s13063-017-2287-7

DO - 10.1186/s13063-017-2287-7

M3 - Review article

AN - SCOPUS:85029449182

VL - 18

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 556

ER -